{"id":128415,"date":"2021-10-02T02:22:44","date_gmt":"2021-10-02T09:22:44","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/10\/dr-leticia-toledo-sherman-senior-director-drug-discovery-tau-consortium-rainwater-foundation"},"modified":"2021-10-02T02:22:44","modified_gmt":"2021-10-02T09:22:44","slug":"dr-leticia-toledo-sherman-senior-director-drug-discovery-tau-consortium-rainwater-foundation","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/10\/dr-leticia-toledo-sherman-senior-director-drug-discovery-tau-consortium-rainwater-foundation","title":{"rendered":"Dr. Leticia Toledo-Sherman \u2014 Senior Director, Drug Discovery, Tau Consortium, Rainwater Foundation"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/DlJLJepiw9Y?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Developing drugs for a range of tauopathies \u2014 dr leticia toledo-sherman, senior director, drug discovery, tau consortium, rainwater charitable foundation.<\/p>\n<hr>\n<p>Dr. Leticia Toledo-Sherman is Senior Director of Drug Discovery of the Tau Consortium (<a href=\"https:\/\/tauconsortium.org\/\">https:\/\/tauconsortium.org\/<\/a>) for The Rainwater Charitable Foundation (<a href=\"https:\/\/rainwatercharitablefoundation.org\/medical-research\">https:\/\/rainwatercharitablefoundation.org\/medical-research<\/a>) and also holds an appointment as Adjunct Assistant Professor of Neurology at UCLA.<\/p>\n<p>Dr. Toledo-Sherman leads drug discovery activities for an international network of scientists working to develop therapies for Tauopathies, a group of neurodegenerative disorders characterized by the deposition of abnormal Tau protein in the brain.<\/p>\n<p>Previously, Dr. Toledo-Sherman was Director of Medicinal Chemistry and Computer-Aided Drug Design at the CHDI Foundation, leading drug discovery programs for therapeutic development in Huntington\u2019s Disease (HD). At CHDI, she also led a structural biology initiative critical to the understanding of the relationship between structure and biological function of huntingtin, the protein that when mutated causes HD.<\/p>\n<p>Prior to joining CHDI, Dr. Toledo-Sherman was Executive Director of Chemistry at Lymphosign (now part of Pharmascience Inc), a privately held biotechnology company that applied rational design principles to the development of therapeutics for blood cancers. From 2000 to 2,004 she led a multi-site, multidisciplinary team using chemical proteomics and bioinformatics to discover therapeutic targets and to investigate the mechanism of action of drugs.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2021\/10\/dr-leticia-toledo-sherman-senior-director-drug-discovery-tau-consortium-rainwater-foundation\">Continue reading \u201cDr. Leticia Toledo-Sherman \u2014 Senior Director, Drug Discovery, Tau Consortium, Rainwater Foundation\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Developing drugs for a range of tauopathies \u2014 dr leticia toledo-sherman, senior director, drug discovery, tau consortium, rainwater charitable foundation. Dr. Leticia Toledo-Sherman is Senior Director of Drug Discovery of the Tau Consortium (https:\/\/tauconsortium.org\/) for The Rainwater Charitable Foundation (https:\/\/rainwatercharitablefoundation.org\/medical-research) and also holds an appointment as Adjunct Assistant Professor of Neurology at UCLA. Dr. Toledo-Sherman [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,1523,47],"tags":[],"class_list":["post-128415","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-computing","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/128415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=128415"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/128415\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=128415"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=128415"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=128415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}